http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108822175-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-0007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2018-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108822175-B |
| titleOfInvention | 3, 16-androstenedione compound and application thereof |
| abstract | The invention discloses a 3, 16-androstenedione compound with a structural formula shown as the following formula or a pharmaceutically acceptable salt thereof, and application thereof in preparing immunosuppressive and antitumor drugs; the compound is extracted and separated from a plant of the genus Sinomenium, and the structural formula of the compound is shown as the following formula: wherein, R is 1 Selected from hydrogen, hydroxyl, methyl, halogen, carbonyl, aliphatic alkyl and aliphatic amino; r 2 Selected from hydrogen, hydroxyl, methyl, halogen, aliphatic hydrocarbon group, aliphatic amino; experiments prove that the compound reported in the invention has strong immunosuppressive and antitumor activities; the compound of the invention provides a lead compound for developing immunosuppressant and antitumor preparation, and is beneficial to developing and utilizing plant medicinal resources. |
| priorityDate | 2018-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.